stockrowTarsus Pharmaceuticals, Inc.
TARS Healthcare Biotechnology
Tarsus Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $451.4 million, up 146.7% from fiscal 2024.
- Revenue
- +63.9%
- EPS
- −4,699.1%
- Free cash flow
- −144.1%
- Total debt
- +0.90%
Quarter to September 2026, against a year earlier
Follow TARS
Alert me
Tarsus Pharmaceuticals, Inc. (TARS) Operating margin
Tarsus Pharmaceuticals, Inc.'s operating margin over the twelve months to 30 September 2026 was −102.0%, down 86.3 percentage points from fiscal 2025 (−15.7%). Over the past ten years it has ranged from −820.5% (fiscal 2023) to 0.00% (fiscal 2020); the current reading is higher than 63% of that period. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −15.7% | 50.18 |
| FY2024 | −65.9% | 754.63 |
| FY2023 | −820.5% | (577.61) |
| FY2022 | −242.9% | (221.60) |
| FY2021 | −21.3% | (21.32) |
| FY2020 | 0.00% | 0.00 |
| FY2019 | 0.00% | 0.00 |
| FY2018 | 0.00% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | −340.3% | (328.84) |
| Jun 2026 | −11.5% | (7.67) |
| Mar 2026 | −3.78% | 1.48 |
| Dec 2025 | −5.26% | 6.98 |
| 24 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| ACAD ACADIA Pharmaceuticals Inc. compare | 10.2% |
| ELVN Enliven Therapeutics, Inc. compare | 0.00% |
| DYN Dyne Therapeutics, Inc. compare | 0.00% |
| CELC Celcuity, Inc. compare | 0.00% |
| VKTX Viking Therapeutics, Inc. compare | 0.00% |
| TARS Tarsus Pharmaceuticals, Inc. | −102.0% |
| VRDN Viridian Therapeutics, Inc. compare | −1,781.4% |
| DNLI Denali Therapeutics Inc. compare | −2,349.0% |
| TLX Telix Pharmaceuticals Limited compare | — |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on TARS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement